Back
Adaptimmune Therapeutics PLC Vs. Shift4 Payments Industry Stock Comparison
Sell
39
ADAP
Adaptimmune Therapeutics PLC
Last Price:
1.04
Seasonality Move:
-2.49%
Buy
72
FOUR
Shift4 Payments
Last Price:
72.85
Seasonality Move:
-4.44%
Sell
39
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.04. The Score for ADAP is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Shift4 Payments (FOUR)
is a Buy
Is Shift4 Payments a Buy, Sell or Hold?
- The current Shift4 Payments [FOUR] share price is $72.77. The Score for FOUR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- FOUR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $1.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
FOUR Stock Price Chart
What is Shift4 Payments's stock price today?
-
The Shift4 Payments share price today is $72.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FOUR is experiencing selling pressure, which indicates risk of future bearish movement.
ADAP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 45.42 | Sell |
Chaikin Money Flow: | -525781 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.02 - 1.14) | Sell |
Bollinger Bands (100): | (0.98 - 1.46) | Sell |
FOUR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.14 | Buy |
Relative Strength Index (14 RSI): | 62.27 | Buy |
Chaikin Money Flow: | -631437 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (64.37 - 71.57) | Buy |
Bollinger Bands (100): | (63.38 - 77.28) | Buy |
ADAP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.04 | Buy |
20-day SMA: | 1.07 | Sell |
50-day SMA: | 1.12 | Sell |
200-day SMA: | 0.93 | Buy |
8-day EMA: | 1.04 | Sell |
20-day EMA: | 1.06 | Sell |
50-day EMA: | 1.12 | Sell |
200-day EMA: | 1.08 | Sell |
FOUR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 71.64 | Buy |
20-day SMA: | 69.18 | Buy |
50-day SMA: | 65.23 | Buy |
200-day SMA: | 65.46 | Buy |
8-day EMA: | 71.5 | Buy |
20-day EMA: | 69.11 | Buy |
50-day EMA: | 67.72 | Buy |
200-day EMA: | 66.64 | Buy |
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.25 per share, and an increase next year of $0.14 per share.
Shift4 Payments Earnings Growth & FOUR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.10 per share, an increase this year of $0.77 per share, and an increase next year of $1.06 per share.
Adaptimmune Therapeutics PLC Technical Analysis
May 30 | May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Shift4 Payments Technical Analysis
May 30 | May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
30 | 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |